Delivery Order SPE2DR25D2205-SPE2DR26F2H22
Award Date 3/6/26
Potential Completion Date 3/9/26
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $5,957.71 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999.00 and extending through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order carries firm...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for ACTEMRA ACTPEN 162 mg/0.9 mL auto-injector pens with a ceiling value of $14,358.07. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999 through December 2026), which supports pharmaceutical supply to military healthcare programs globally. Ultimate completion date is February 3, 2026....
- The Defense Logistics Agency issued a $9,379.16 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides global pharmaceutical support across multiple therapeutic domains to military healthcare programs. Place of performance is Conshohocken, PA. The order was awarded on a firm...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, with a ceiling value of $8,986.71 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA. The ultimate completion date is February 3, 2026. Pricing is firm fixed price. The order was issued under a non-set-aside basis. This delivery order is called against the company's parent IDC with DLA Troop Support Medical, a $999.999 million indefinite...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, with a ceiling value of $96,241.41, for Actemra Actpen 162 mg/0.9 ml pharmaceutical supply. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 5, 2026, and is priced on a firm fixed-price basis with no set-aside applied. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle through...
- The Defense Logistics Agency issued a $5,237.78 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Actemra Actpen 162 mg/0.9 mL pharmaceutical supply. The order is placed against AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The ultimate...
- The Defense Logistics Agency issued a $1,501.74 delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Actemra (tocilizumab) 162 mg/0.9 mL auto-injector pens under a firm fixed-price structure. The order's ultimate completion date is March 9, 2026. Place of performance is Conshohocken, PA. The order was not set-aside. This delivery order is issued under the company's parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Actemra 162 mg/0.9 ml syringes with a ceiling value of $12,043.64. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at up to $999,999,999.00 through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $58,983.31 for supply of Actemra 162 mg/0.9 mL syringes. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs...
- <p>The Defense Logistics Agency issued a $3,010.67 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Actemra 162 mg/0.9 mL syringes.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 9, 2026.</p>